Shannon, November 16, 2021 — Compuscript is delighted to announce the launch of a new academic journal, Acta Materia Medica.
Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management.
Coverage includes:
- Pathophysiology of important diseases and disease vectors
- Novel therapeutic strategies
- Novel methodologies facilitating the search for therapies
- High-throughput screening, combinatorial chemistry, parallel synthesis and library design
- 3D Structures and functions of therapeutic targets
- Structural biological studies of relevant ligands and targets
- Discovery, design and synthesis of biologically active agents, including natural products, therapeutic macromolecules
- Drug delivery
- ADME/Toxicology
- Advances in key compound classes and therapeutic areas
- Omics in pharmaceutical sciences
- Biological databases, web-based software for pharmaceutical sciences
- Studies of biological activity or mode of action.
- Structure-activity correlations of drugs
- Development of new imaging and diagnostic tools
- Computational studies the SAR of compounds, target informatics
- Business strategy for pharmaceutical industry
- Clinical research and trials, meta-analysis
- Management, commercial and regulatory issues in pharmaceutical R&D.
- Other aspects of pharmacy and pharmaceutical sciences.
Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
Submission Process
Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed
Hongxi Xu, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China and Wenyi Wei, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA as inaugural Co-Editors-in-Chief (see the full editorial team here: https://amm-journal.org/index.php/editorial-board/ ).
Queries about the journal can be sent to editorialoffice@amm-journal.org.
For more information about the journal, including article submission guidelines and how to register for free content-alerting services, please visit: https://amm-journal.org/
The editors of Acta Materia Medica look forward to stewarding the journal through this exciting new phase in the development of the field of pharmaceutical research.
Acta Materia Medica is now open for submissions via ScholarOne (https://mc04.manuscriptcentral.com/ammed).
There are no author submission or article processing fees.
Please visit https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
Twitter: @AMM_journal
eISSN 2737-7946